EFPIA - NEWSLETTER

EFPIA Newsletter 13 October 2022

Blogs

13 October 2022 Research and innovation is providing new hope for patients today – where will it happen tomorrow?...

Explore some of the breakthrough innovations that will help address unmet need in many disease areas and bring benefits...

11 October 2022 Updated Council Recommendation on cancer screening: a positive step in the fight against cancer...

If the EU is to be at the forefront of the fight against cancer, the timely implementation of the Recommendation by...

07 October 2022 A European Union that leads on cancer screening: the implications of new Council recommendation...

Whilst the next step will be for the EU Council to negotiate a final recommendation, we must work together to ensure...

Sustaining rapid medicine development: lessons from a pandemic

A report by Economist Impact, sponsored by Merck, exploring how stakeholders were able to move so quickly during a global crisis. The main takeaway: the many changes in process applied during the pandemic could aid the development of future medicines, especially with the help of advanced manufacturing.

Events

10 NOV 2022

Investor Perspective: The Strategic Venturing Spectrum Hybrid

Webinar by Johnson & Johnson Innovation

Learn more →

15 NOV 2022

EU HEALTH SUMMIT 2022: TOWARDS AN EU HEALTH UNION Brussels

An EU Health Coalition event

Learn more →

Interested in the use and acceptance of digital endpoints?

We need your help to complete a survey meant to further assess the current status of digital endpoints used in drug development and to collect experience in the current environment and feedback on what the barriers and potential solutions are: https://lnkd.in/efCCnWds

Deadline for survey completion: 10 November 2022.

What we are reading

Transferable Exclusivity Extension Vouchers Are Viable In Europe, But Back Up Required 07 October 2022 (Pink Sheet)

Breast cancer survival rates soar thanks to wave of treatment advances 06 October 2022 (The Times)

Solving unfair access to medicines: good intentions don’t guarantee good results 04 October 2022 (Euractiv)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶